Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

119
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
119
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

484
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
484
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

216
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
216

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Simulation and Case Study to Evaluate the Extrapolation Performance of Flexible Bayesian Survival Models when Incorporating Real-World Data.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same author

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same author

Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study.

Cancer research communications·2026
Same author

Efficacy and optimal dose of acetic acid for treating colonised burns wounds (AceticA): a double-blind, single Centre, randomised, controlled phase II trial.

Journal of burn care & research : official publication of the American Burn Association·2025
Same author

Ceralasertib, an ATR kinase inhibitor, as monotherapy in Japanese patients with advanced solid malignancies: Results from a phase 1 study.

Investigational new drugs·2025
Same author

Population Health and Health Inequality Impacts of the National Abdominal Aortic Aneurysm Screening Programme (NAAASP) in England.

Medical decision making : an international journal of the Society for Medical Decision Making·2025

Related Experiment Video

Updated: May 26, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.6K

Potential outcome simulation for efficient head-to-head comparison of adaptive dose-finding designs.

Michael Sweeting1, Daniel Slade2, Dan Jackson1

  • 1Statistical Innovation, Oncology Biometrics, AstraZeneca, Cambridge, CB2 8PA, United Kingdom.

Biometrics
|February 24, 2025
PubMed
Summary

This study introduces a novel, efficient simulation method for dose-finding trials, significantly reducing computational time and Monte Carlo error. The approach enhances the comparison of statistical designs by simulating all potential outcomes in advance.

Keywords:
MCMC erroradaptive designsdose-findingpotential outcomessimulation

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.7K
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.4K

Related Experiment Videos

Last Updated: May 26, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.6K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.7K
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.4K

Area of Science:

  • Pharmacometrics
  • Biostatistics
  • Clinical Trial Design

Background:

  • Dose-finding trials are crucial for drug development, requiring statistical designs to guide dosing decisions.
  • Evaluating competing dose-finding designs typically involves time-consuming large-scale simulation studies.
  • Current simulation methods limit the scope due to extensive computational requirements.

Purpose of the Study:

  • To introduce a more efficient simulation approach for designing and evaluating dose-finding trials.
  • To enable faster and more comprehensive head-to-head comparisons of different statistical designs.
  • To reduce the computational burden and Monte Carlo error in simulation studies.

Main Methods:

  • Simulating all potential individual outcomes at each dose level in advance.
  • Applying pre-simulated datasets to multiple competing dose-finding designs for comparison.
  • Utilizing advance-simulated datasets for assessing design performance across various configurations.

Main Results:

  • Demonstrated substantial reductions in Monte Carlo error for comparing design performance metrics.
  • Showcased efficiency gains, with one case study requiring a 48-times smaller simulation study.
  • Highlighted the reusability of advance-simulated datasets for multiple configurations.

Conclusions:

  • The new simulation approach offers significant efficiency gains for dose-finding trial evaluations.
  • Researchers are encouraged to adopt this method for more robust and efficient simulation studies.
  • The R package 'escalation' has been updated to support the implementation of this new approach.